MARKET

VRNA

VRNA

Verona Pharma
NASDAQ
39.57
+0.31
+0.80%
Opening 12:22 12/13 EST
OPEN
39.22
PREV CLOSE
39.26
HIGH
39.93
LOW
39.15
VOLUME
98.18K
TURNOVER
--
52 WEEK HIGH
40.97
52 WEEK LOW
11.39
MARKET CAP
3.24B
P/E (TTM)
-20.8613
1D
5D
1M
3M
1Y
5Y
1D
Verona Pharma (VRNA) Gets a Buy from Truist Financial
TipRanks · 3d ago
Weekly Report: what happened at VRNA last week (1202-1206)?
Weekly Report · 4d ago
Insider Sale: President and CEO of $VRNA (VRNA) Sells 162,800 Shares
Barchart · 6d ago
Insider Sale: Chief Financial Officer of $VRNA (VRNA) Sells 12,936 Shares
Barchart · 12/03 04:32
Jefferies Sticks to Their Buy Rating for Verona Pharma (VRNA)
TipRanks · 12/02 13:16
Weekly Report: what happened at VRNA last week (1125-1129)?
Weekly Report · 12/02 10:12
Verona Pharma: In COPD, There's A Corner With Their Name On It
Seeking Alpha · 11/27 14:12
Weekly Report: what happened at VRNA last week (1118-1122)?
Weekly Report · 11/25 10:08
More
About VRNA
Verona Pharma Plc is a United Kingdom-based biopharmaceutical company. The Company is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. It is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The Company's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The Company's wholly owned subsidiary is Verona Pharma, Inc.

Webull offers Verona Pharma PLC - ADR stock information, including NASDAQ: VRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRNA stock methods without spending real money on the virtual paper trading platform.